InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: Penny Double post# 84852

Monday, 12/19/2016 6:20:59 PM

Monday, December 19, 2016 6:20:59 PM

Post# of 465858
If Anavex were to patent and market Anavex Plus only, that would suck for those that are intolerant to donepezil, for which there are many. From a biochemical perspective, I would expect donepezil to hinder the effectiveness of 273 (hogs the sigma 1 receptors without doing anything there of benefit and proven to antagonize the activity of muscarinic agonists). Ph 2 results suggest that it does indeed do that
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News